Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Alberts

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trialMace L Rothenberg, P Y Liu, Patricia S Braly, et al.
The Journal of Supportive Oncology|January 27, 2011
Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancerLisa M Hess, Setsuko K Chambers, Kenneth Hatch, et al.
Gynecologic Oncology|December 14, 2004
Role of pegylated liposomal doxorubicin in ovarian cancerJ Tate Thigpen, Carol A Aghajanian, David S Alberts, et al.
Cancer Biology & Therapy|December 23, 2003
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progressionA-C Goulet, Janine G Einsphar, David S Alberts, et al.
Nutrition and Cancer|April 30, 2005
Diet and biomarkers of oxidative damage in women previously treated for breast cancerCynthia A Thomson, Anna R Giuliano, James W Shaw, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 19, 2010
Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer studyH-H Sherry Chow, Linda L Garland, Chiu-Hsieh Hsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2003
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase geneMaria Elena Martinez, Thomas G O'Brien, Kimberly E Fultz, et al.
Nutrition and Cancer|April 30, 2008
The nutritional prevention of cancer: 400 mcg per day selenium treatmentMary E Reid, Anna J Duffield-Lillico, Elizabeth Slate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2023
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the CervixWilliam A Peters, P Y Liu, Rolland J Barrett, et al.
Gynecologic Oncology|March 4, 2008
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survivalDavid S Alberts, Christian Marth, Ronald D Alvarez, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trialMace L Rothenberg, P Y Liu, Patricia S Braly, et al.
The Journal of Supportive Oncology|January 27, 2011
Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancerLisa M Hess, Setsuko K Chambers, Kenneth Hatch, et al.
Gynecologic Oncology|December 14, 2004
Role of pegylated liposomal doxorubicin in ovarian cancerJ Tate Thigpen, Carol A Aghajanian, David S Alberts, et al.
Cancer Biology & Therapy|December 23, 2003
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progressionA-C Goulet, Janine G Einsphar, David S Alberts, et al.
Nutrition and Cancer|April 30, 2005
Diet and biomarkers of oxidative damage in women previously treated for breast cancerCynthia A Thomson, Anna R Giuliano, James W Shaw, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 19, 2010
Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer studyH-H Sherry Chow, Linda L Garland, Chiu-Hsieh Hsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2003
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase geneMaria Elena Martinez, Thomas G O'Brien, Kimberly E Fultz, et al.
Nutrition and Cancer|April 30, 2008
The nutritional prevention of cancer: 400 mcg per day selenium treatmentMary E Reid, Anna J Duffield-Lillico, Elizabeth Slate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2023
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the CervixWilliam A Peters, P Y Liu, Rolland J Barrett, et al.
Gynecologic Oncology|March 4, 2008
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survivalDavid S Alberts, Christian Marth, Ronald D Alvarez, et al.
Pageof 19